What is ilaprazole medicine

Effectiveness and safety of a week-long triple therapy with ilaprazole for the eradication of Helicobacter pylori

Inclusion criteria:

- The subject must be endoscopically confirmed on gastric ulcers (including scars). or gastritis confirmed as H. pylori positive patient in biopsy and UBT tests.

- Subject who fully understands the conditions of the clinical trial.

- Subject who agrees to participate and spontaneously signs the ICF

Exclusion criteria:

- Known hypersensitivity to components of ilaprazole, esoprazole, amoxicillin and clarithromycin

- Subjects taking contraindicated drugs for experimental and concomitant purposes Medicines

- Administration of PPIs, antibiotic drugs within 4 weeks before the start of the study

- Pregnant and / or breastfeeding women

- women of childbearing potential who are not using contraception

- Uncontrolled diabetics

- uncontrolled high blood pressure

- Uncontrolled liver dysfunction

- alcoholics

- Subjects with a history of digestive malignancies within 5 years

- Patients with a history of gastrectomy or esophagectomy

- Patients with hereditary diseases such as galactose intolerance, lapp lactose deficiency, glucose-galactose malabsorption

- Subjects who participate in a clinical study within 30 days of another study

- Subject assessed inconsistently by the researcher